Table 2. Summary of the cross-sectional age-corrected QSM observations. Statistical significance measured with Wilcoxon rank sum test (one-tailed).
ROI | QSM (ppb) | Baseline ALS vs. control subjects | |||
---|---|---|---|---|---|
Control subjects, mean ± SEM | Baseline ALS, mean ± SEM | P value | Cohen’s d | ||
Left primary motor area (anterior) | 27.8±0.9 | 29.6±1.0 | 0.12 | 0.57 | |
Right primary motor area (anterior) | 29.7±1.1 | 33.0±0.9 | 0.02* | 0.92 | |
Left primary motor area (posterior) | 27.0±0.8 | 30.2±1.2 | 0.02* | 0.9 | |
Right primary motor area (posterior) | 28.3±0.8 | 30.3±1.1 | 0.09 | 0.58 | |
Left pre-motor area | 23.1±0.6 | 24.4±0.8 | 0.23 | 0.50 | |
Right pre-motor area | 23.2±0.5 | 24.6±1.0 | 0.09 | 0.47 |
QSM, quantitative susceptibility mapping; ALS, amyotrophic lateral sclerosis; SEM, standard error of the mean; ROI, region of interest.